Overview
Paradox Biosciences develops next-generation small-molecule therapeutics targeting synaptic plasticity pathways for the treatment of treatment-resistant depression and PTSD.
More in Neuropharmaceuticals
Latest industry news
China Sets Global Precedent With World's First AI-Enabled BCI Medical Device Standard
2026-09-15 · Policy
Austin Brain Implant Lets Patient Communicate in Real Time: 'I Have a Lot to Say'
2026-09-14 · Research
ReVision Implant Secures €4 Million to Push Visual Neuroprosthetics Forward
2026-09-13 · Funding
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Reimagine Neuroscience
2026-09-12 · Funding
Company details
Category
💊 Neuropharmaceuticals
Location
San Diego, CA
Funding
Series A — $42M
Website
paradoxbiosciences.comListed
2026-08-31
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →